BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $72,000 | -21.7% | 68,434 | +25.9% | 0.00% | -20.0% |
| Q2 2019 | $92,000 | +80.4% | 54,339 | +256.6% | 0.01% | +66.7% |
| Q1 2019 | $51,000 | +18.6% | 15,239 | +4.3% | 0.00% | 0.0% |
| Q4 2018 | $43,000 | -74.9% | 14,615 | -47.5% | 0.00% | -62.5% |
| Q3 2018 | $171,000 | -70.4% | 27,828 | -68.4% | 0.01% | -65.2% |
| Q1 2018 | $577,000 | -33.6% | 88,012 | +105.3% | 0.02% | -43.9% |
| Q4 2015 | $869,000 | +246.2% | 42,878 | +148.2% | 0.04% | +355.6% |
| Q3 2015 | $251,000 | – | 17,278 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,051,441 | $3,070,000 | 0.79% |
| X-Square Capital, LLC | 109,832 | $321,000 | 0.25% |
| KNOTT DAVID M | 111,427 | $325,000 | 0.15% |
| ARK Investment Management | 1,033,491 | $3,018,000 | 0.12% |
| Baker Brothers Advisors | 2,677,818 | $7,819,000 | 0.06% |
| HARVEY CAPITAL MANAGEMENT INC | 31,200 | $91,000 | 0.05% |
| DAFNA Capital Management LLC | 30,000 | $88,000 | 0.04% |
| WASATCH ADVISORS LP | 953,368 | $2,784,000 | 0.04% |
| FRANKLIN STREET ADVISORS INC /NC | 51,415 | $150,000 | 0.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,000,000 | $2,920,000 | 0.02% |